• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌基因产物HER2/Neu和Ras以及纤维化相关生长因子bFGF、TGF-β和PDGF在胆道恶性肿瘤和炎症性疾病胆汁中的表达。

Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.

作者信息

Su W C, Shiesh S C, Liu H S, Chen C Y, Chow N H, Lin X Z

机构信息

Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Dig Dis Sci. 2001 Jul;46(7):1387-92. doi: 10.1023/a:1010619316436.

DOI:10.1023/a:1010619316436
PMID:11478488
Abstract

The expression of several growth factors and K-ras gene mutation in bile were studied to better understand the pathogenesis and improve early diagnosis of bile duct cancers. Bile samples were collected from 12 cholangiocarcinomas (CLC), 10 ampullary cancers (APC), 3 gallbladder cancers (GBC), 7 pancreatic cancers (PNC), 9 biliary tract infection (BTI), 8 biliary stone disease (ST), and 5 normal controls (NC). The highest mean value of TGF-beta in bile was in patients with BTI; the mean levels of bFGF and PDGF were highest in CLC, and patients with APC and CLC had higher expression of HER2/Neu than other groups. In bile, a K-ras gene codon 12 mutation was found in 5 of 6 (83%) cases of CLC by the PCR-RFLP method. The results suggest overexpression of bFGF, PDGF, and HER2/Neu and the presence of K-ras mutation are important for carcinogenesis of bile duct cancers, and detection of the above abnormalities in bile is helpful for early diagnosis.

摘要

研究胆汁中几种生长因子的表达及K-ras基因突变,以更好地理解胆管癌的发病机制并改善其早期诊断。收集了12例胆管癌(CLC)、10例壶腹癌(APC)、3例胆囊癌(GBC)、7例胰腺癌(PNC)、9例胆道感染(BTI)、8例胆石症(ST)患者的胆汁样本以及5例正常对照(NC)的胆汁样本。胆汁中转化生长因子-β(TGF-β)的平均最高值出现在BTI患者中;碱性成纤维细胞生长因子(bFGF)和血小板衍生生长因子(PDGF)的平均水平在CLC患者中最高,APC和CLC患者中HER2/Neu的表达高于其他组。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法,在6例CLC患者中的5例(83%)胆汁样本中发现了K-ras基因密码子12突变。结果表明,bFGF、PDGF和HER2/Neu的过表达以及K-ras突变的存在对胆管癌的致癌作用很重要,检测胆汁中的上述异常有助于早期诊断。

相似文献

1
Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.致癌基因产物HER2/Neu和Ras以及纤维化相关生长因子bFGF、TGF-β和PDGF在胆道恶性肿瘤和炎症性疾病胆汁中的表达。
Dig Dis Sci. 2001 Jul;46(7):1387-92. doi: 10.1023/a:1010619316436.
2
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.比较胆道癌患者手术后基于炎症的预后评分。
Anticancer Res. 2021 Apr;41(4):2147-2155. doi: 10.21873/anticanres.14987.
3
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
4
Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.检测活检标本和胆汁中端粒酶逆转录酶mRNA用于诊断胆道癌。
Int J Mol Med. 2001 Mar;7(3):281-7. doi: 10.3892/ijmm.7.3.281.
5
Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Int J Oncol. 1998 May;12(5):1019-23. doi: 10.3892/ijo.12.5.1019.
6
K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.胆管癌活检标本及胆汁中K-ras第12密码子和p53突变情况
Pathol Int. 1999 Jan;49(1):30-7. doi: 10.1046/j.1440-1827.1999.00821.x.
7
Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.通过肽核酸介导的聚合酶链反应钳夹和熔解曲线分析快速检测胆汁中的K-ras突变:与限制性片段长度多态性分析的比较
Clin Chem. 2004 Mar;50(3):481-9. doi: 10.1373/clinchem.2003.024505. Epub 2004 Jan 12.
8
Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.c-erbB-2、表皮生长因子受体和c-met在胆管癌中的扩增及过表达。
J Pathol. 2005 Jul;206(3):356-65. doi: 10.1002/path.1779.
9
Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.石蜡包埋组织切片中壶腹周围癌、胆囊癌和胆管癌的K-ras基因突变分析
J Formos Med Assoc. 1995 Dec;94(12):719-23.
10
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.血清及胆汁中胰岛素样生长因子I和血管内皮生长因子在梗阻性胆汁淤积病因诊断中的作用
Ann Intern Med. 2007 Oct 2;147(7):451-9. doi: 10.7326/0003-4819-147-7-200710020-00003.

引用本文的文献

1
Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer.胆管癌抗血管生成机制研究与临床治疗的最新进展
Front Oncol. 2021 Oct 28;11:777617. doi: 10.3389/fonc.2021.777617. eCollection 2021.
2
Lymphatic vasculature in tumor metastasis and immunobiology.肿瘤转移和免疫生物学中的淋巴管系统
J Zhejiang Univ Sci B. 2019 Jul 12;21(1):3-11. doi: 10.1631/jzus.B1800633.
3
Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.胆囊癌的基因组学:生物标志物驱动的临床试验设计理由

本文引用的文献

1
Biliary tract cancers.胆道癌
N Engl J Med. 1999 Oct 28;341(18):1368-78. doi: 10.1056/NEJM199910283411807.
2
Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells.磷酸肌醇3激酶/蛋白激酶B(Akt)与丝裂原活化蛋白激酶(ERK/p38MAPK)平衡的改变决定了内脏和血管平滑肌细胞的表型。
J Cell Biol. 1999 May 17;145(4):727-40. doi: 10.1083/jcb.145.4.727.
3
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Cancer Metastasis Rev. 2016 Jun;35(2):263-75. doi: 10.1007/s10555-016-9602-8.
4
Prognostıc value of increased HER2 expression in cancers of pancreas and biliary tree.HER2表达增加在胰腺癌和胆管癌中的预后价值。
Pathol Oncol Res. 2015 Jul;21(3):831-8. doi: 10.1007/s12253-014-9847-x. Epub 2014 Nov 23.
5
Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.HER2/neu基因过表达:晚期胆囊癌患者的一种新治疗可能性
Gastrointest Cancer Res. 2014 Mar;7(2):42-8.
6
The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.胆管癌的挑战:剖析阴险癌症的分子机制。
Dis Model Mech. 2013 Mar;6(2):281-92. doi: 10.1242/dmm.010561.
7
HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.HER3 过表达是肝外胆管癌的预后指标。
Virchows Arch. 2012 Nov;461(5):521-30. doi: 10.1007/s00428-012-1321-0. Epub 2012 Oct 2.
8
Basic fibroblast growth factor induces cholangiocarcinoma cell migration via activation of the MEK1/2 pathway.碱性成纤维细胞生长因子通过激活MEK1/2信号通路诱导胆管癌细胞迁移。
Oncol Lett. 2011 Sep 1;2(5):821-825. doi: 10.3892/ol.2011.333. Epub 2011 Jun 29.
9
Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.胆管癌:流行病学、危险因素、发病机制及诊断
Curr Gastroenterol Rep. 2011 Apr;13(2):182-7. doi: 10.1007/s11894-011-0178-8.
10
New insights on cholangiocarcinoma.胆管癌的新见解。
World J Gastrointest Oncol. 2010 Mar 15;2(3):136-45. doi: 10.4251/wjgo.v2.i3.136.
致癌性Ras对TGFβ/Smad信号通路的一种抑制机制。
Genes Dev. 1999 Apr 1;13(7):804-16. doi: 10.1101/gad.13.7.804.
4
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.胰腺和胆管腺癌中转化生长因子β受体基因的遗传改变。
Cancer Res. 1998 Dec 1;58(23):5329-32.
5
Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma.
Dig Dis Sci. 1998 Oct;43(10):2261-6. doi: 10.1023/a:1026670723302.
6
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Cancer Res. 1998 Mar 15;58(6):1124-6.
7
TGF-beta signalling from cell membrane to nucleus through SMAD proteins.转化生长因子-β(TGF-β)通过SMAD蛋白从细胞膜向细胞核传递信号。
Nature. 1997 Dec 4;390(6659):465-71. doi: 10.1038/37284.
8
A clinical study of 130 patients with biliary tract cancers and periampullary tumors.
Oncology. 1996 Nov-Dec;53(6):488-93. doi: 10.1159/000227625.
9
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.转化生长因子-β1(TGF-β1)与Ha-Ras共同作用,调节上皮肿瘤细胞的表型可塑性和侵袭性。
Genes Dev. 1996 Oct 1;10(19):2462-77. doi: 10.1101/gad.10.19.2462.
10
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.《波士顿贝斯以色列医院医学研讨会。肝纤维化的细胞基础。机制与治疗策略》
N Engl J Med. 1993 Jun 24;328(25):1828-35. doi: 10.1056/NEJM199306243282508.